» Articles » PMID: 15663785

Asthma is a Risk Factor for Acute Chest Syndrome and Cerebral Vascular Accidents in Children with Sickle Cell Disease

Overview
Publisher Biomed Central
Date 2005 Jan 25
PMID 15663785
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND: Asthma and sickle cell disease are common conditions that both may result in pulmonary complications. We hypothesized that children with sickle cell disease with concomitant asthma have an increased incidence of vaso-occlusive crises that are complicated by episodes of acute chest syndrome. METHODS: A 5-year retrospective chart analysis was performed investigating 48 children ages 3-18 years with asthma and sickle cell disease and 48 children with sickle cell disease alone. Children were matched for age, gender, and type of sickle cell defect. Hospital admissions were recorded for acute chest syndrome, cerebral vascular accident, vaso-occlusive pain crises, and blood transfusions (total, exchange and chronic). Mann-Whitney test and Chi square analysis were used to assess differences between the groups. RESULTS: Children with sickle cell disease and asthma had significantly more episodes of acute chest syndrome (p = 0.03) and cerebral vascular accidents (p = 0.05) compared to children with sickle cell disease without asthma. As expected, these children received more total blood transfusions (p = 0.01) and chronic transfusions (p = 0.04). Admissions for vasoocclusive pain crises and exchange transfusions were not statistically different between cases and controls. SS disease is more severe than SC disease. CONCLUSIONS: Children with concomitant asthma and sickle cell disease have increased episodes of acute chest syndrome, cerebral vascular accidents and the need for blood transfusions. Whether aggressive asthma therapy can reduce these complications in this subset of children is unknown and requires further studies.

Citing Articles

The Cardiopulmonary Complications of Sickle Cell Disease.

Desai A, Machado R, Cohen R Hematol Oncol Clin North Am. 2022; 36(6):1217-1237.

PMID: 36400540 PMC: 10323820. DOI: 10.1016/j.hoc.2022.07.014.


Sickle Cell Disease and Its Respiratory Complications.

Khan M, Patel N, Meda R, Nuguru S, Rachakonda S, Sripathi S Cureus. 2022; 14(8):e28528.

PMID: 36185937 PMC: 9517690. DOI: 10.7759/cureus.28528.


End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Farrell A, Panepinto J, Desai A, Kassim A, Lebensburger J, Walters M Blood Adv. 2019; 3(23):4002-4020.

PMID: 31809537 PMC: 6963248. DOI: 10.1182/bloodadvances.2019000883.


Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Marti-Carvajal A, Conterno L, Knight-Madden J Cochrane Database Syst Rev. 2019; 9:CD006110.

PMID: 31531967 PMC: 6749554. DOI: 10.1002/14651858.CD006110.pub5.


How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.

Machogu E, Machado R Blood. 2018; 132(17):1770-1780.

PMID: 30206115 PMC: 6202915. DOI: 10.1182/blood-2018-03-818195.


References
1.
Leong M, Dampier C, Varlotta L, Allen J . Airway hyperreactivity in children with sickle cell disease. J Pediatr. 1997; 131(2):278-83. DOI: 10.1016/s0022-3476(97)70166-5. View

2.
POWARS D, Weidman J, Niland J, JOHNSON C . Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 1988; 67(1):66-76. View

3.
Bernini J, Rogers Z, Sandler E, Reisch J, Quinn C, Buchanan G . Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998; 92(9):3082-9. View

4.
Koumbourlis A, Zar H, Hurlet-Jensen A, Goldberg M . Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr. 2001; 138(2):188-92. DOI: 10.1067/mpd.2001.111824. View

5.
Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, Dean D . Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000; 342(25):1855-65. DOI: 10.1056/NEJM200006223422502. View